Become a Partner
Opioid Disparities Shed Light on Potential Implicit Bias in Medicine
Close to Home: Lower drug prices might limit access
Tackling the ‘disease of systemic racism’ in clinical trials
The pandemic has pushed children’s mental health and access to care to a ‘crisis point’
California’s effort to eliminate deductibles on prescription drugs for individuals with chronic conditions is a “tremendous idea,” says expert
Lavishly paid and unapologetic. Company at center of Medicaid scandal focuses on profits.
FDA adds new warning on Johnson & Johnson vaccine related to rare autoimmune disorder
Pfizer to seek OK for 3rd vaccine dose; shots still protect
Federal Lawmakers Question Tenet’s Use of CARES Act Funds
Patient Drug Prices Can Vary by $50 a Pill Among U.S. Hospitals
Sign up for updates
Tweets by CaAccess
© 2020 California Partnership for Access to Treatment (CPAT). Supported by America's Biopharmaceutical Research Companies.